Evaluating the Performance and Safety of the Medical Device Janesse in the Treatment of Facial Dermal Tissue Defects

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

September 13, 2022

Study Completion Date

September 13, 2022

Conditions
CicatrixLipodystrophyPlaque
Interventions
DEVICE

Janesse

"Device: Janesse® is a sterile, injectable, non-pyrogenic, re-absorbable medical product made of reticulated hyaluronic acid of non-animal origin, produced via bacterial fermentation.~The subjects will receive at baseline the first investigational medical device by the Investigator in accordance with the clinical investigation plan."

Trial Locations (1)

300425

SCM Dr. Rosu, Timișoara

All Listed Sponsors
collaborator

Opera CRO, a TIGERMED Group Company

OTHER

lead

I.R.A. Istituto Ricerche Applicate S.p.A.

NETWORK